- {{heading}}
- Ab00268-10.0 Anti-SARS-CoV S glycoprotein [S230]
- SARS Coronavirus
- Human IgG1
- Purified
- In Stock
- Ab00268-23.0 Anti-SARS-CoV S glycoprotein [S230]
- SARS Coronavirus
- Rabbit IgG
- Purified
- In Stock
Recombinant monoclonal antibody to SARS-CoV S glycoprotein. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the EBV transformed human B cell clone S230.
Alternative Name(s) of Target: Severe Acute Respiratory Syndrome Coronavirus GP
Immunogen: Made by immortalizing IgG-expressing B cells from recovered SARS patients.
Specificity: This antibody specifically recognizes S protein of SARS-CoV.
Antibody first published in: Rockx B, Corti D, Donaldson E, Sheahan T, Stadler K, Lanzavecchia A, Baric R. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic Severe Acute Respiratory Syndrome CoronaVirus challenge. J Virol. 2008 Apr;82(7):3220-35. doi: 10.1128/JVI.02377-07. Epub 2008 Jan 16. PMID:18199635